您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Oxidopamine hydrochloride
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Oxidopamine hydrochloride
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Oxidopamine hydrochloride图片
CAS NO:28094-15-7
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议
200mg电议
500mg电议

产品名称
6-羟基多巴胺盐酸盐
6-Hydroxydopamine hydrochloride
6-OHDA hydrochloride
产品介绍
Oxidopamine (6-OHDA) hydrochloride 是神经递质多巴胺 (neurotransmitter dopamine) 的拮抗剂。Oxidopamine hydrochloride 是一种广泛应用的神经毒素,可选择性破坏多巴胺能神经元。Oxidopamine hydrochloride 促进COX-2激活,导致PGE2合成和促炎细胞因子IL-1β的分泌。Oxidopamine hydrochloride 可用于帕金森病 (PD)、注意缺陷多动障碍 (ADHD) 和莱施奈恩综合症的研究。
生物活性

Oxidopamine (6-OHDA) hydrochloride is an antagonist of theneurotransmitter dopamine. Oxidopamine hydrochloride is a widely used neurotoxin and selectively destroys dopaminergic neurons. Oxidopamine hydrochloride promotesCOX-2activation, leading toPGE2synthesis and pro-inflammatory cytokineIL-1βsecretion. Oxidopamine hydrochloride can be used for the research of Parkinson’s disease (PD), attention-deficit hyperactivity disorder (ADHD), and Lesch-Nyhan syndrome[1][2][3][4].

IC50& Target

COX-2

 

IL-1β

 

Caspase-3

 

Caspase-8

 

Caspase-9

 

体外研究
(In Vitro)

Oxidopamine hydrochloride (0-500 μM, 24 h) decreases the viability of both Neuro-2a cells and SH-SY5Y cells in a concentration-dependent manner[1].
Oxidopamine hydrochloride (75-150 μM, 0-24 h) induces COX-2 expression and nuclear translocation[1].
Oxidopamine hydrochloride (75-150 μM, 0-24 h) causes PGE2biosynthesis and pro-inflammatory cytokine IL-1β production[1].
Oxidopamine hydrochloride (0-150 μM, 12 h) inducesapoptosisand mitochondrial membrane depolarization of pheochromocytoma PC12 cells[3].
Oxidopamine hydrochloride (75 μM, 0-12 h) induces p38 phosphorylation[3].

Cell Viability Assay[1]

Cell Line:Neuro-2a cells and SH-SY5Y cells
Concentration:0-500 μM
Incubation Time:24 or 48 h
Result:Induced neurotoxicity, caused cytotoxicity in both Neuro-2a cells and SH-SY5Y cells in a concentration dependent manner. EC50=111 μM for 24 h incubation and 109 μM for 48 h incubation in the Neuro-2a cells; EC50=118 μM for 24 h incubation and 107 μM for 48 h incubation in the SH-SY5Y cells.

RT-PCR[1]

Cell Line:Neuro-2a cells and SH-SY5Y cells
Concentration:75 or 150 μM
Incubation Time:0, 6 or 24 h
Result:Quickly and robustly induced COX-2 in a time-dependent manner. Induced COX-2 activation characterized by expression induction and nuclear translocation. Substantially increased PGE2in the culture medium by nearly 5-fold in Neuro-2a cells (at 75 μM) and 3-fold in SH-SY5Y cells (at 150 μM). Significantly upregulated the pro-inflammatory cytokine interleukin-1β (IL-1β) within Neuro-2a cells and SH-SY5Y cells.

Apoptosis Analysis[3]

Cell Line:PC12 cells
Concentration:0, 25, 50, 75, and 150 μM
Incubation Time:0, 2, 4, 6, 12, and 20 h
Result:Induced apoptosis of PC12 cells. Increased the activities of caspase-3, -8 and -9 in PC12 cells in a time- and concentration-dependent manner. Increased these caspase activities at 2-4 h and reached a maximum at 12 h. Decreased cells with high mitochondrial membrane potential (JC-1 aggregate) in a time- and concentration-dependent manner.

Western Blot Analysis[3]

Cell Line:PC12 cells
Concentration:75 μM
Incubation Time:0, 3, 5, 6, 8, 10, and 12 h
Result:Increased the level of p-p38 in a time-dependent manner.
体内研究
(In Vivo)

Oxidopamine hydrochloride (5 μg/2 μL, unilaterally injected into the right striatum) induces degeneration of dopaminergic neurons in substantia nigra of rats[2].

分子量

205.64

性状

Solid

Formula

C8H12ClNO3

CAS 号

28094-15-7

中文名称

6-羟基多巴胺盐酸盐

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, stored under nitrogen

*该产品在溶液状态不稳定,建议您现用现配,即刻使用。

溶解性数据
In Vitro: 

H2O : 100 mg/mL(486.29 mM;Need ultrasonic)

DMSO : 83.33 mg/mL(405.22 mM;Need ultrasonic)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM4.8629 mL24.3143 mL48.6287 mL
5 mM0.9726 mL4.8629 mL9.7257 mL
10 mM0.4863 mL2.4314 mL4.8629 mL
*

请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液;该产品在溶液状态不稳定,建议您现用现配,即刻使用

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: PBS

    Solubility: 100 mg/mL (486.29 mM); Clear solution; Need ultrasonic

  • 2.

    请依序添加每种溶剂: 10% DMSO    40%PEG300   5%Tween-80   45% saline

    Solubility: ≥ 2.08 mg/mL (10.11 mM); Clear solution

    此方案可获得 ≥ 2.08 mg/mL (10.11 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH2O 中,得到澄清透明的生理盐水溶液
  • 3.

    请依序添加每种溶剂: 10% DMSO    90% (20%SBE-β-CDin saline)

    Solubility: ≥ 2.08 mg/mL (10.11 mM); Clear solution

    此方案可获得 ≥ 2.08 mg/mL (10.11 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。

    将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中,再用生理盐水定容至 10 mL,完全溶解,澄清透明
*以上所有助溶剂都可在本网站选购。